Charles Russell Speechlys has been replaced as one of Cancer Research’s core legal advisers by national firm Michelmores.

Michelmores has claimed the spot from Charles Russell Speechlys after a review of the charity’s legacy panel.

Cancer Research has selected Michelmores as its sole provider, with the firm’s disputed wills and trusts team taking the lead on the pitch.

Michelmores disputed wills and trusts partner Tony Cockayne leads the team, supported by senior associate Barry Croft and solicitor Jasmine Davis.

The trio will advise Cancer Research on disputes arising from money left in legacies. In 2016/17, over 6,000 legacies were left to the charity totalling £187m.

Cancer Research also has a general advisory panel for corporate and regulatory matters, with Withers continuing to act as the charity’s main UK adviser.

The general panel is understood to have been unaffected by the review of Cancer Research’s legacy disputes panel.

Legacy work is handled by former Shoosmiths lawyer and head of legacy administration Maria King, while Cancer Research’s legal team is run by Nicki Ford.

Ford joined the company in 2012 and started her legal career at Denton Wilde Sapte. She was promoted to head of legal in 2015 taking on the reins from general counsel Clare Shepherd.

Charles Russell Speechlys was contacted for comment.